Warren C. Lau

HoustonPharma, Inc. develops pharmaceutical products and technologies. It develops oncolytic virus technologies for the treatment of cancer, including ovarian cancer, glioblastoma, and multiple myeloma. The company is headquartered in Malvern, PA.

YouBlast Global, Inc. is a development stage company, which develops and operates digital lifestyle portals. The company's principal activities include marketing services to advertisers and publishers, such as display advertising and search advertising, on the company's social publishing network, YouBlast.com, and across its affiliate web properties, such as Honeymag.com; web publishing services to users, such as single-click publishing tools, click to CDN streaming tools, advanced web and file analytics and single click e-commerce tools; enterprise solutions for companies seeking to sub-license and custom-brand YouBlast products and services on a broader scale. It is a one-stop-shop for internet users and businesses to create a rich website with easy to use publishing, analytics and e-commerce tools. YouBlast Global was founded on September 26, 1997 and is headquartered in Miami Beach, FL.

Photovoltaic Solar Cells, Inc. is a development stage company. It engages in identifying, investigating and if warranted, acquiring companies. The company was founded by Lawrence F. Curtin on March 28, 2007 and is headquartered in New York, NY.

Part of Ngen, Inc., Synthetic Genetics is an American company that provides a broad line of modified obligonucleotides, including research probes to the research market. The company was founded by Richard H. Tullis. Synthetic Genetics was acquired by Epoch Biosciences, Inc., a subsidiary of Ngen, Inc. from Immune Complex Corp. on November 21, 2000 for $3.10 million.

Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX.

Nexus BioPharma Corp. engages in the development of a drug to treat obesity. The firm specializes in obesity and diabetes. The company is headquartered in Montclair, NJ.